DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio

Thursday, 15 October 2015

Csaba Hetenyi

OCM Member

Csaba Hetenyi

Research Associate Professor
Hungarian Academy of Sciences, Hungary
E-mail megerősítve itt: caesar.elte.hu - Kezdőlap

Csaba Hetényi
Dr. Csaba Hetenyi is a Qualified Chemist, and a PhD in Pharmacy. He has co-authored research articles in prestigious journals J Am Chem Soc, PNAS, EMBO Reports, Bioinformatics, and is also a co-inventor of US patents.
Dr. Hetenyi has received more than one thousand citations for his research results and his works were favorably evaluated by several review articles and research papers.
In 2011, Dr. Hetenyi won a Talentum Academy Award for his research achievements. His primary interest is focused on chemical biophysics, computational and medicinal chemistry, structural bioinformatics, molecular pathomechanisms of diseases.
He has also contributed to publications in the fields of chromatography and capillary electrophoresis.
Dr. Hetenyi works in Hungary with three PhD students.
PhD, Pharmacy (summa cum laude), Faculty of Pharmacy, University of Szeged, Hungary, 2002.
MSc, Qualified Chemist (with distinction), Faculty of Science, University of Szeged, Hungary, 1999.
Research interests General: Chemical biophysics Computational and medicinal chemistry Structural bioinformatics Molecular pathomechanism of diseases Chromatography and capillary electrophoresis (formerly) Specific: Molecular mechanics & dynamics, docking Calculation of macromolecular structures and ligand-target interactions Thermodynamics of molecular complexes Quantitative structure-activity relationships Computer-aided drug design Application of quantum chemical methods
Profile picture


Sr. Research Fellow

Hungarian Academy of Sciences
June 2012 – Present (3 years 5 months)Budapest
MTA-ELTE Molecular Biophysics Research Group

Sr. Research Fellow

Eötvös University
December 2009 – May 2012 (2 years 6 months)
Research and teaching.

Visiting Scientist

Uppsala University
July 2009 – December 2009 (6 months)Uppsala, Sweden

Sr. Researcher

University of Tartu
2006 – 2008 (2 years)
Teaching, research.
Molecular Biophysics Research Group, Hungarian Academy of Sciences
c/o Dept. of Biochemistry, Eotvos University
Pazmany stny. 1/C, 1117 Budapest, Hungary
Room 7.427
Phone 1: +3614116500/8697
Phone 2: +3613812171
Fax: +3613812172


University of Szeged

PhD, Pharmacy
1999 – 2002

University of Szeged

MSc, Chemistry
1994 – 1999
Dr. Csaba Hetényi is a Research Associate Professor at the Molecular Biophysics Research Group of the Hungarian Academy of Sciences. He is a qualified chemist and has a PhD in Pharmacy. He has co-authored research articles in prestigious journals such as J Am Chem Soc, EMBO Reports, FASEB J, etc. and has already received more than one thousand citations for his research results. His works were favorably evaluated by several review articles. He is also co-inventor in three US patents. In 2011, Dr. Hetényi received the prestigious Talentum Academy Award of the Central-European Talent Search Foundation. Dr. Hetényi’s primary research interests focus on chemical biophysics, computational and medicinal chemistry, structural bioinformatics, molecular pathomechanisms of diseases, and he has also published works in the fields of chromatography and capillary electrophoresis.
Chemical biophysics, computational and medicinal chemistry, structural bioinformatics 

Jeszenoi N, Horvath I, Balint M, van der Spoel D, Hetenyi C* (2015) Mobility-based prediction of hydration structures of protein surfaces.
Bioinformatics, 31, 1959-65
Program MobyWat is available here
Garcia-Sosa AT, Maran U, Hetenyi C* (2012) Molecular property filters describing pharmacokinetics and drug binding.
Curr Med Chem 19, 1646-62
Hetenyi C*, van der Spoel D (2011) Toward prediction of functional protein pockets using blind docking and pocket search algorithms.
Protein Sci 20, 880-93
Takacs B, O'Neall-Hennessey E, Hetenyi C, Kardos J, Szent-Gyorgyi AG, Kovacs M (2011) Myosin cleft closure determines the energetics of the actomyosin interaction.
FASEB J 25, 111-21
Org T, Chignola F, Hetenyi C, Gaetani M, Rebane A, Liiv I, Maran U, Mollica L, Bottomley MJ, Musco G, Peterson P (2008) The Autoimmune Regulator PHD finger binds non-methylated Histone H3K4 to activate gene expression.
EMBO Reports 9, 370-6
Hetenyi C*, Maran U, Garcia-Sosa AT, Karelson M (2007) Structure-based calculation of drug efficiency indices.
Bioinformatics 23, 2678-85
Hetenyi C*, van der Spoel D (2006) Blind docking of drug-sized compounds to proteins with up to a thousand residues.
FEBS Letters 580, 1447-50
Hetenyi C*, Paragi G, Maran U, Timar Z, Karelson M, Penke B (2006) Combination of a modified scoring function with two-dimensional descriptors for calculation of binding affinities of bulky, flexible ligands to proteins.
J Am Chem Soc 128, 1233-9
Fodor K, Harmat V, Hetenyi C, Kardos J, Antal J, Perczel A, Patthy A, Katona G, Graf L (2005) Extended intermolecular interactions in a serine protease-canonical inhibitor complex account for strong and highly specific inhibition.
J Mol Biol 350, 156-69
Kovacs M, Toth J, Hetenyi C, Malnasi-Csizmadia A, Sellers JR (2004) Mechanism of blebbistatin inhibition of myosin II.
J Biol Chem 279, 35557-63
Hetenyi C*, Szabo Z, Klement E, Datki Z, Kortvelyesi T, Zarandi M, Penke B (2002) Pentapeptide amides interfere with the aggregation of beta amyloid peptide of Alzheimer's disease.
Biochem Biophys Res Comm, 292, 931-6
Hetenyi C, van der Spoel D (2002) Efficient docking of peptides to proteins without prior knowledge of the binding site.
Protein Sci, 11, 1729-37
Hetenyi C*, Kortvelyesi T, Penke B (2002) Mapping of the possible binding sequences of two beta-sheet breaker peptides on beta amyloid peptide of Alzheimer's disease.
Bioorgan Med Chem, 10, 1587-93

TEACHING MATERIAL (password protected pages)
Introduction to structural modeling of bioactive molecules
Calculation of molecular interactions
Protein science (in Hungarian, ELTE MSc course)
Professional activities
PhD supervisor of three PhD students
Lecturer of PhD and MSc courses in protein science, structural bioinformatics of drug design, calculation of molecular interactions, and medical chemistry
Member of doctoral committees, doctoral examiner, and doctoral opponent (several times)
Member of scientific societies: American Chemical Society (USA, -2013), The Protein Society (USA) Member of organizing committee of conference MedChem & CADD-2013 (Las Vegas, USA) Referee of scientific journals J Am Chem Soc, Proteins, Protein Sci, Expert Opin Drug Discov, J Comput Chem, J Comput-Aided Mol Design, J Chem Inf Model, Bioorgan Med Chem, Mini Rev Med Chem, Plos Comp Biol, Chem Phys Lett, Food and Chemical Toxicology Prizes 2013 Bolyai Diploma for outstanding research work in the period of 2009-2012 Bolyai Curatory, Hungarian Academy of Sciences 2011 Talentum Academy Award Central-European Talent Search Foundation, Hungarian Academy of Sciences, amount: 20 000 EUR 1999 Special prize for MSc Thesis Hungarian Chemical Society

Hungarian Academy of Sciences

Eötvös University

/////Csaba Hetenyi, Hungarian Academy of Sciences , Eötvös University

No comments:

Post a Comment